Boosting NAD with nicotinamide (niacinamide), a form of vitamin B3, has been shown in phase 3 human randomized controlled trials to prevent skin cancer in high risk patients. It has also shown promising results in animal models against a variety of other cancers.
(This is evidence that it is oversimplified to claim that boosting NAD promotes cancer growth in humans, as some have done.)


